tiprankstipranks
Trending News
More News >
iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market
Advertisement

iX Biopharma Ltd. (42C) Income Statement

Compare
10 Followers

iX Biopharma Ltd. Income Statement

Last quarter (Q4 2024), iX Biopharma Ltd.'s total revenue was S$4.05M, an increase of 139.53% from the same quarter last year. In Q4, iX Biopharma Ltd.'s net income was S$-3.89M. See iX Biopharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
S$ 7.77MS$ 5.96MS$ 5.91MS$ 14.39MS$ 1.75M
Gross Profit
S$ 2.04MS$ 1.05MS$ 2.32MS$ 12.29MS$ -382.00K
Operating Expenses
S$ 8.32MS$ 8.44MS$ 10.73MS$ 11.05MS$ 11.05M
Depreciation and Amortization
S$ 854.00KS$ 868.00KS$ 929.00KS$ 1.06MS$ 642.00K
EBITDA
S$ -8.96MS$ -8.68MS$ -8.51MS$ -2.84MS$ -10.79M
Operating Income
S$ -6.29MS$ -7.39MS$ -8.41MS$ 1.24MS$ -11.43M
Other Income/Expenses
S$ -3.85MS$ -2.60MS$ -1.29MS$ -5.34MS$ 3.20M
Pretax Income
S$ -10.14MS$ -9.98MS$ -9.71MS$ -4.10MS$ -8.23M
Net Income
S$ -10.14MS$ -10.79MS$ -9.62MS$ -4.60MS$ -8.23M
Per Share Metrics
Basic EPS
S$ -0.01S$ -0.01S$ -0.01S$ -0.01S$ -0.01
Diluted EPS
S$ -0.01S$ -0.01S$ -0.01S$ -0.01S$ -0.01
Weighted Average Shares Outstanding
874.22M 767.36M 764.85M 754.63M 691.93M
Weighted Average Shares Outstanding (Diluted)
876.68M 767.36M 764.85M 754.63M 693.41M
Currency in SGD

iX Biopharma Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis